GlobeImmune (United States)

Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B

Anna S. Lok, Calvin Q. Pan, Steven-Huy Han et al. · Journal of Hepatology · 2016 · 172 citations

Vaccination, Vaccine Development, Viral Hepatitis +8

Population Pharmacokinetic Analysis of Anidulafungin, an Echinocandin Antifungal

James A. Dowell, William Knebel, Tom Ludden et al. · The Journal of Clinical Pharmacology · 2004 · 168 citations

Serious Fungal Disease, Analysis Population, Antifungal Agent +8

Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury

Christopher R. Heery, B. Harpreet Singh, Myrna Rauckhorst et al. · Cancer Immunology Research · 2015 · 136 citations · Full text

Immunology, Immunoediting, Pathology +16

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

Carolina Boni, Harry L.A. Janssen, Marzia Rossi et al. · Gastroenterology · 2019 · 134 citations · Full text

Viral Persistence, Hepatology, Hbv-specific T-cell Responses +11

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins

Aurelia A. Haller, Georg M. Lauer, Thomas H. King et al. · Vaccine · 2006 · 105 citations

Adaptive Immune System, T-regulatory Cell, Immunology +9